You are here: Industry Insights > Vaccine

News List

J&J Accelerates COVID-19 Vaccine Candidate americanpharmaceuticalreview
June 22, 2020
Johnson & Johnson announced through Janssen Pharmaceutical, it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant.
CureVac Receives Approval to Initiate Clinical Trial of SARS-CoV-2 Vaccine Candidate contractpharma
June 18, 2020
The Belgian Federal Agency for Medicines and Health Products (FAMHP) has approved the Phase 1 clinical trial for CureVac’s vaccine program to prevent SARS-CoV-2 infection. The trial will be conducted in Germany and Belgium.
EU calls for global alliance to buy COVID-19 vaccines up front expresspharma
June 18, 2020
It is planning to spend around $2.3 billion on the advance purchase of vaccines in testing on behalf of the 27 EU states.
Germany to invest €300m in CureVac’s mRNA platform technology pharmaceutical-technology
June 17, 2020
The German Federal Government is set to invest €300m in CureVac, a biotechnology company focused on using messenger RNA (mRNA) technology to develop drugs and vaccines.
Sanofi Invests $679M in Two French Vaccine Sites contractpharma
June 17, 2020
Will create a state-of-the-art vaccine production site and a new research center dedicated to vaccines.
BioNTech to receive up to €100m from EIB for vaccine development pharmaceutical-technology
June 15, 2020
German immunotherapy company BioNTech has signed a €100m debt financing agreement with the European Investment Bank (EIB) for the development of its Covid-19 vaccine candidate, BNT162.
EMA gives positive opinion to investigational Ebola vaccine regimen europeanpharmaceuticalreview
June 09, 2020
Developed by Janssen, the two-dose regimen has already been given to 60,000 patients and now has the positive opinion of the Committee for Medicinal Products for Human Use (CHMP).
Australia’s CSL says to help fund, make vaccine candidate if it proves successful expresspharma
June 08, 2020
Early pre-clinical results for the vaccine candidate have shown it produced high levels of antibodies that can neutralise the virus, CSL said.
Te Herenga Waka—Victoria University, NZ professor receives funding boost for vaccine research expresspharma
June 03, 2020
Te Herenga Waka—Victoria University of Wellington Associate Professor Bridget Stocker has received a significant funding boost for vaccine research that has potential to help with diseases ranging from bowel cancer to COVID-19.
New vaccine for Ebola among CHMP recommendations pharmatimes
June 02, 2020
Johnson and Johnson's experimental two-stage vaccine for protection against Ebola virus disease is among eight medicines backed by the European Medicines Agency's human medicines committee (CHMP) at its May meeting.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page